-
Chloramphenicol: Selection With Transmission in Mind
2026-08-16
Chloramphenicol is more than a plasmid-selection antibiotic: it is a controllable variable in experiments studying plasmid maintenance, localization, and transfer. This guide connects its ribosomal mechanism and formulation requirements with the transmission-focused findings of a recent CREC study.
-
HCMV UL88 Targets MyD88 to Limit Innate Immunity
2026-08-15
Kumar and colleagues identify the HCMV tegument protein UL88 as a viral antagonist that associates with and reduces the innate immune adaptor MyD88. Their experiments connect UL88-dependent MyD88 regulation with NF-κB signaling, soluble antiviral activity, interferon-stimulated gene expression, and virus spread between myeloid cells and fibroblasts.
-
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-08-14
Schüller et al. showed that pentoxifylline suppresses LPS-induced inflammatory activation in monocytes from preterm infants, with effects spanning surface phenotype, cytokine release, phagocytosis, and TLR4 signaling. The age-stratified whole-blood model provides a useful framework for evaluating neonatal immunomodulation without assuming that adult sepsis biology applies directly to preterm infants.
-
E-64: From Protease Control to Viral Inflammation
2026-08-14
E-64 is an irreversible L-trans-epoxysuccinyl peptide that gives translational researchers a practical way to interrogate cysteine protease activity, cathepsin biology, invasion, and cell-death phenotypes. By placing this benchmark inhibitor alongside evidence that viral proteins regulate RIPK3 degradation and necroptosis, this article develops a cautious strategy for connecting protease activity with inflammatory disease mechanisms without overstating direct causality.
-
Linoleic Acid (C18:2): Protocol Guide
2026-08-13
This guide explains how to use Linoleic Acid (C18:2(9Z,12Z), SKU C3108) in oxidative stress, erythrocyte, membrane, migration, and nutritional deficiency workflows. It is suited to freshly prepared solvent-based experiments, but not to aqueous-only protocols or studies that require long-term stock-solution stability.
-
Reactive Oxygen Species Assay Kit for Mitophagy
2026-08-13
Learn how to use a DHE-based Reactive Oxygen Species Assay Kit to quantify intracellular superoxide in live-cell fibrosis and mitophagy experiments. The workflow emphasizes treatment-response design, PINK1–Parkin interpretation, controls, and troubleshooting rather than treating fluorescence as a standalone disease marker.
-
TaqI Restriction Endonuclease Protocol
2026-08-12
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the 5′-TCGA-3′ recognition site. It is intended for controlled research workflows such as cloning and DNA mapping, not for diagnostic or medical use.
-
OCT2/MATE1 Inhibition by 5-HT3 Antagonists
2026-08-12
George and colleagues developed a comparative in vitro framework to test how five 5-HT3 antagonist drugs affect the renal organic cation transporters OCT2 and MATE1. The results show that transporter inhibition is drug- and transporter-specific, providing a mechanistic basis for evaluating possible effects on renal cation secretion without equating cell-based findings with confirmed clinical drug interactions.
-
Fasting, Fatty Acids, and Translational Control in Cancer
2026-08-11
Yang and colleagues show that fasting suppresses global hepatic translation while selectively activating a P-eIF4E-dependent translatome for lipid catabolism and ketogenesis. Their work identifies an AMPK–MNK–eIF4E pathway linking fatty-acid signaling to diet-induced metabolic remodeling and provides preclinical rationale for combining ketogenic diets with P-eIF4E inhibition in pancreatic cancer.
-
Carbapenemase Gene Transfer in CREC Across Guangdong
2026-08-11
Chen et al. integrate gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and strain typing to characterize carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study shows that plasmid-associated blaNDM-1 is both common and readily transferable, highlighting the need to distinguish clonal spread from horizontal resistance-gene dissemination.
-
TaqI Restriction Endonuclease: Practical Guide
2026-08-10
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA for research workflows. It is useful for sticky-end cloning and DNA mapping, but product-specific reaction conditions must be validated and the enzyme is not intended for diagnostic or medical use.
-
ApexPrep DNA Miniprep for AML Research
2026-08-09
The ApexPrep DNA Plasmid Miniprep Kit provides molecular biology grade plasmid DNA for cloning, sequencing, and robust-cell-line transfection. This guide connects alkaline lysis workflow design with practical assay decisions inspired by the LMO2–LDB1 AML study.
-
Indazole/Indole Glucagon Antagonists: Study Insights
2026-08-08
This 2015 study describes indazole-, indole-, and azaindole-based glucagon receptor antagonists derived from the MK-0893 design concept. Its structure–activity relationship work identified compounds with strong in vitro properties, favorable rat pharmacokinetics, and oral activity in humanized glucagon receptor mouse models, including GRA 16d.
-
3-Deazaneplanocin (DZNep): Mechanism & Use
2026-08-07
3-Deazaneplanocin, also called DZNep, is an S-adenosylhomocysteine hydrolase inhibitor and epigenetic modulator with reported activity against EZH2-associated methylation programs. Preclinical evidence supports apoptosis induction in AML cells, hepatocellular carcinoma research, and cancer stem cell targeting, but model-specific validation remains essential.
-
Oxaliplatin in Translational Oncology: Mechanism, Models, an
2026-08-07
This thought-leadership article explores the mechanistic sophistication and translational value of Oxaliplatin, a platinum-based chemotherapeutic agent, with a focus on its role in overcoming resistance and optimizing experimental workflows. Integrating insights from recent mechanistic studies, validated protocols, and the competitive landscape, the article delivers actionable guidance for translational researchers navigating the complexity of preclinical and clinical oncology research.